Shares of Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report) fell 0.5% during mid-day trading on Wednesday . The stock traded as low as $0.94 and last traded at $0.94. 2,402 shares traded hands during trading, a decline of 11% from the average session volume of 2,709 shares. The stock had previously closed at $0.94.
Fresh Tracks Therapeutics Stock Performance
The stock has a market capitalization of $5.58 million, a P/E ratio of -0.66 and a beta of 0.54. The business has a 50-day moving average price of $0.93 and a 200 day moving average price of $0.79.
About Fresh Tracks Therapeutics
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
See Also
- Five stocks we like better than Fresh Tracks Therapeutics
- Why is the Ex-Dividend Date Significant to Investors?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Top Biotech Stocks: Exploring Innovation Opportunities
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What is Insider Trading? What You Can Learn from Insider Trading
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
